NEW YORK (GenomeWeb News) — The National Science Foundation has given Protelica a $500,000 grant to continue developing its DNA mutagenesis technologies in a bioinformatics-based project aimed at developing protein therapies, the company said today.

Protelica will use the two-year, Phase II Small Business Innovation Research funding to develop "a bioinformatics-based understanding of nature’s evolutionary rules, and utilizes Protelica's proprietary DNA mutagenesis technologies to develop small, specific and potent protein blockers," the company said.